John Wagstaff

3 ta ish

Cornell University

1. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

   James Larkin, Vanna Chiarion‐Sileni, René González +28

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170114

2. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

   Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González +30

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.082822

3. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

   Robert J. Motzer, Bernard Escudier, Ray McDermott +24

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.679071